Nierkens, S., Eijkelkamp, N., Nederend, M., Leusen, J., Evers, M., Stip, M., . . . Meyer-Wentrup, F. (2021). Anti-GD2 IgA kills tumors by neutrophils without antibody-associated pain in the preclinical treatment of high-risk neuroblastoma. BMJ Publishing Group.
Chicago Style (17th ed.) CitationNierkens, Stefan, et al. Anti-GD2 IgA Kills Tumors by Neutrophils Without Antibody-associated Pain in the Preclinical Treatment of High-risk Neuroblastoma. BMJ Publishing Group, 2021.
MLA (8th ed.) CitationNierkens, Stefan, et al. Anti-GD2 IgA Kills Tumors by Neutrophils Without Antibody-associated Pain in the Preclinical Treatment of High-risk Neuroblastoma. BMJ Publishing Group, 2021.
Warning: These citations may not always be 100% accurate.